A microfluidic channel method for rapid drug-susceptibility testing of Pseudomonas aeruginosa

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Matsumoto, Yoshimi ^a   Sakakihara, Shouichi ^a   Grushnikov, Andrey ^a   Kikuchi, Kazuma ^a   Noji, Hiroyuki ^b   Yamaguchi, Akihito ^a   Iino, Ryota ^c,d   Yagi, Yasushi ^a   Nishino, Kunihiko ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OKAZAKI INSTITUTE FOR INTEGRATIVE BIOSCIENCE   (Japan)

^d GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; MEROPENEM; PIPERACILLIN; ANTIINFECTIVE AGENT; THIENAMYCIN DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATION; BROTH DILUTION; CELL SHAPE; CONTROLLED STUDY; DRUG EFFECT; INCUBATION TIME; MICROFLUIDICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SPHEROPLAST; DRUG EFFECTS; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; LAB ON A CHIP; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; PROCEDURES;

AMIKACIN; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; LAB-ON-A-CHIP DEVICES; MICROBIAL SENSITIVITY TESTS; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; THIENAMYCINS;

EID: 84960511208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148797     Document Type: Article

References (68)

1. Hakki M, Limaye AP, Kim HW, Kirby KA, Corey L, Boeckh M. Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplant. 2007;39:687-93. PMID: 17401395
2. Wagner VE, Iglewski BH. P. aeruginosa Biofilms in CF Infection. Clin Rev Allergy Immunol. 2008;35:124-34. doi: 10.1007/s12016-008-8079-9 PMID: 18509765
3. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science. 1994;264:382-8. PMID: 8153625
4. Schweizer HP. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res. 2003;2:48-62. PMID: 12917802
5. Pages JM, James CE, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nature Reviews Microbiology. 2008;6(12):893-903. doi: 10.1038/nrmicro1994 PMID: ISI:000260903500011.
6. Henrichfreise B, Wiegand I, Pfister W, Wiedemann B. Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother. 2007;51:4062-70. PMID: 17876002
7. Giske CG, Buaro L, Sundsfjord A, Wretlind B. Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa. Microb Drug Resist. 2008;14:23-30. doi: 10.1089/mdr.2008.0778 PMID: 18321207
8. Kirikae T, Mizuguchi Y, Arakawa Y. Investigation of isolation rates of Pseudomonas aeruginosa with and without multidrug resistance in medical facilities and clinical laboratories in Japan. J Antimicrob Chemother. 2008;61:612-5. doi: 10.1093/jac/dkm537 PMID: 18238884
9. Sekiguchi J, Teruya K, Horii K, Kuroda E, Konosaki H, Mizuguchi Y, et al. Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital. J Infect Chemother. 2007;13:418-22. PMID: 18095093
10. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, et al. Outbreaks of multidrugresistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol. 2007;45:979-89. PMID: 17122009
11. Satoh R, Tsukada H, Tanabe Y, Tamura Y, Yamamoto T, Takano M, et al. An outbreak and isolation of drug-resistant Pseudomonas aeruginosa at Niigata University Hospital, Japan. J Infect Chemother. 2008;14:325-9. doi: 10.1007/s10156-008-0620-5 PMID: 18709539
12. Aoki N, Tateda K, Kikuchi Y, Kimura S, Miyazaki C, Ishii Y, et al. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother. 2009;63:534-42. doi: 10.1093/jac/dkn530 PMID: 19147523
13. Mesaros N, Nordmann P, Plesiat P, Roussel-Delvallez M, Van Eldere J, Glupczynski Y, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect. 2007;13:560-78. PMID: 17266725
14. Strateva T, Yordanov D. Pseudomonas aeruginosa-a phenomenon of bacterial resistance. J Med Microbiol. 2009;58(Pt 9):1133-48. Epub 2009/06/17. jmm.0.009142-0 [pii] doi: 10.1099/jmm.0. 009142-0 PMID: 19528173.
15. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare? Clinical Infectious Diseases. 2002;34(5):634-40. PMID: ISI:000173677600012.
16. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22:582-610. doi: 10.1128/CMR.00040-09 PMID: 19822890
17. Huang H, Hancock RE. Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa. J Bacteriol. 1993;175(24):7793-800. Epub 1993/12/01. PMID: 8253668.
18. Kohler T, Michea-Hamzehpour M, Epp SF, Pechere JC. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob Agents Chemother. 1999;43(2):424-7. Epub 1999/01/30. PMID: 9925552.
19. Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S. A highly carbapenemresistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. J Antimicrob Chemother. 2007;60:132-5. PMID: 17483142
20. Quale J, Bratu S, Gupta J, Landman D. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2006;50(5):1633-41. Epub 2006/04/28. 50/5/1633 [pii] doi: 10.1128/AAC.50.5.1633-1641.2006 PMID: 16641429.
21. Ballestero S, Fernandez-Rodriguez A, Villaverde R, Escobar H, Perez-Diaz JC, Baquero F. Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients. J Antimicrob Chemother. 1996;38(1):39-45. Epub 1996/07/01. PMID: 8858455.
22. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect. 2002;8(6):321-31. Epub 2002/06/27. 401 [pii]. PMID: 12084099.
23. Senda K, Arakawa Y, Nakashima K, Ito H, Ichiyama S, Shimokata K, et al. Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob Agents Chemother. 1996;40:349-53. PMID: 8834878
24. Koh TH, Yamaguchi K, Ishii Y. Characterisation of the metallo-beta-lactamase VIM-6 and its genetic support. Int J Antimicrob Agents. 2008;32(5):446-9. Epub 2008/09/02. S0924-8579 (08) 00266-5 [pii] doi: 10.1016/j.ijantimicag.2008.05.017 PMID: 18757180.
25. Kimura S, Ishii Y, Yamaguchi K. Evaluation of dipicolinic acid for detection of IMP- or VIM-type metallobetalactamase-producing Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis. 2005;53:241-4. PMID: 16243474
26. Ryan BM, Dougherty TJ, Beaulieu D, Chuang J, Dougherty BA, Barrett JF. Efflux in bacteria: what do we really know about it? Expert Opin Investig Drugs. 2001;10:1409-22. PMID: 11772259
27. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T. Substrate specificities of MexABOprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:3322-7. PMID: 11083635
28. Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Plesiat P. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother. 2004;48:1797-802. PMID: 15105137
29. Morita Y, Kimura N, Mima T, Mizushima T, Tsuchiya T. Roles of MexXY- and MexAB-multidrug efflux pumps in intrinsic multidrug resistance of Pseudomonas aeruginosa PAO1. J Gen Appl Microbiol. 2001;47:27-32. PMID: 12483565
30. Akasaka T, Tanaka M, Yamaguchi A, Sato K. Type II topoisomerase mutations in fluoroquinoloneresistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother. 2001;45(8):2263-8. Epub 2001/07/14. doi: 10.1128/AAC.45.8.2263-2268.2001 PMID: 11451683.
31. Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005;49:479-87. PMID: 15673721
32. Nakajima A, Sugimoto Y, Yoneyama H, Nakae T. High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation. Microbiol Immunol. 2002;46:391-5. PMID: 12153116
33. Morita Y, Kimura N, Mima T, Mizushima T, Tsuchiya T. Roles of MexXY- and MexAB-multidrug efflux pumps in intrinsic multidrug resistance of Pseudomonas aeruginosa PAO1. Journal of General and Applied Microbiology. 2001;47(1):27-32. PMID: ISI:000169047700003.
34. Giske CG, Buaro L, Sundsfjord A, Wretlind B. Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa. Microbial Drug Resistance. 2008;14(1):23-30. doi: 10.1089/mdr.2008.0778 PMID: WOS:000254870900004.
35. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Fujino T, Kobayashi I, Morita K, et al. Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac (6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase. Antimicrob Agents Chemother. 2005;49:3734-42. PMID: 16127047
36. El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. APMIS. 2005;113:187-96. PMID: 15799762
37. Lay JO, Holland RD. Rapid identification of bacteria based on spectral patterns using MALDI-TOFMS. Methods Mol Biol. 2000;146:461-87. doi: 10.1385/1-59259-045-4:461 PMID: 10948519.
38. Barnini S, Ghelardi E, Brucculeri V, Morici P, Lupetti A. Rapid and reliable identification of Gram-negative bacteria and Gram-positive cocci by deposition of bacteria harvested from blood cultures onto the MALDI-TOF plate. BMC Microbiol. 2015;15:124. doi: 10.1186/s12866-015-0459-8 PMID: 26084329; PubMed Central PMCID: PMCPMC4471905.
39. Matsumoto Y, Hayama K, Sakakihara S, Nishino K, Noji H, Iino R, et al. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS One. 2011;6(4):e18547. doi: 10. 1371/journal.pone.0018547 PMID: 21533264; PubMed Central PMCID: PMCPMC3075257.
40. Iino R, Nishino K, Noji H, Yamaguchi A, Matsumoto Y. A microfluidic device for simple and rapid evaluation of multidrug efflux pump inhibitors. Front Microbiol. 2012;3:40. doi: 10.3389/fmicb.2012.00040 PMID: 22347225; PubMed Central PMCID: PMCPMC3274760.
41. Iino R, Matsumoto Y, Nishino K, Yamaguchi A, Noji H. Design of a large-scale femtoliter droplet array for single-cell analysis of drug-tolerant and drug-resistant bacteria. Front Microbiol. 2013;4:300. doi: 10.3389/fmicb.2013.00300 PMID: 24109478; PubMed Central PMCID: PMCPMC3790107.
42. Choi J, Yoo J, Lee M, Kim EG, Lee JS, Lee S, et al. A rapid antimicrobial susceptibility test based on single-cell morphological analysis. Sci Transl Med. 2014;6(267):267ra174. doi: 10.1126/scitranslmed. 3009650 PMID: 25520395.
43. Peitz I, Van Leeuwen R. Single-cell bacteria growth monitoring by automated DEP-facilitated image analysis. Lab Chip. 2010;10(21):2944-51. doi: 10.1039/c004691d PMID: 20842296.
44. Chen CH, Lu Y, Sin ML, Mach KE, Zhang DD, Gau V, et al. Antimicrobial susceptibility testing using high surface-to-volume ratio microchannels. Anal Chem. 2010;82(3):1012-9. doi: 10.1021/ac9022764 PMID: 20055494; PubMed Central PMCID: PMCPMC2821038.
45. Kinnunen P, McNaughton BH, Albertson T, Sinn I, Mofakham S, Elbez R, et al. Self-assembled magnetic bead biosensor for measuring bacterial growth and antimicrobial susceptibility testing. Small. 2012;8(16):2477-82. doi: 10.1002/smll.201200110 PMID: 22674520; PubMed Central PMCID: PMCPMC3625966.
46. Kalashnikov M, Lee JC, Campbell J, Sharon A, Sauer-Budge AF. A microfluidic platform for rapid, stress-induced antibiotic susceptibility testing of Staphylococcus aureus. Lab Chip. 2012;12(21):4523-32. doi: 10.1039/c2lc40531h PMID: 22968495; PubMed Central PMCID: PMCPMC3489182.
47. Lu Y, Gao J, Zhang DD, Gau V, Liao JC, Wong PK. Single cell antimicrobial susceptibility testing by confined microchannels and electrokinetic loading. Anal Chem. 2013;85(8):3971-6. doi: 10.1021/ac4004248 PMID: 23445209; PubMed Central PMCID: PMCPMC4102406.
48. Mohan R, Mukherjee A, Sevgen SE, Sanpitakseree C, Lee J, Schroeder CM, et al. A multiplexed microfluidic platform for rapid antibiotic susceptibility testing. Biosens Bioelectron. 2013;49:118-25. doi: 10. 1016/j.bios.2013.04.046 PMID: 23728197.
49. Takagi R, Fukuda J, Nagata K, Yawata Y, Nomura N, Suzuki H. A microfluidic microbial culture device for rapid determination of the minimum inhibitory concentration of antibiotics. Analyst. 2013;138(4):1000-3. doi: 10.1039/c2an36323b PMID: 23289096.
50. Fredborg M, Andersen KR, Jørgensen E, Droce A, Olesen T, Jensen BB, et al. Real-time optical antimicrobial susceptibility testing. J Clin Microbiol. 2013;51(7):2047-53. doi: 10.1128/JCM.00440-13 PMID: 23596243; PubMed Central PMCID: PMCPMC3697729.
51. Hou Z, An Y, Hjort K, Sandegren L, Wu Z. Time lapse investigation of antibiotic susceptibility using a microfluidic linear gradient 3D culture device. Lab Chip. 2014;14(17):3409-18. doi: 10.1039/c4lc00451e PMID: 25007721.
52. Burnham CA, Frobel RA, Herrera ML, Wickes BL. Rapid ertapenem susceptibility testing and Klebsiella pneumoniae carbapenemase phenotype detection in Klebsiella pneumoniae isolates by use of automated microscopy of immobilized live bacterial cells. J Clin Microbiol. 2014;52(3):982-6. doi: 10.1128/JCM.03255-13 PMID: 24391202; PubMed Central PMCID: PMCPMC3957783.
53. Institute Ca LS. Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Seventh Edition: Approved Standard M7-A7. Wayne, PA, USA: CLSI; 2006.
54. Whitesides GM, Ostuni E, Takayama S, Jiang XY, Ingber DE. Soft lithography in biology and biochemistry. Annual Review of Biomedical Engineering. 2001;3:335-73. PMID: WOS:000170775500014.
55. Alva A, Aquino F, Gilman RH, Olivares C, Requena D, Gutiérrez AH, et al. Morphological characterization of Mycobacterium tuberculosis in a MODS culture for an automatic diagnostics through pattern recognition. PLoS One. 2013;8(12):e82809. doi: 10.1371/journal.pone.0082809 PMID: 24358227; PubMed Central PMCID: PMCPMC3865090.
56. Den Hertog AL, Menting S, Smienk ET, Werngren J, Hoffner S, Anthony RM. Evaluation of a microcolony growth monitoring method for the rapid determination of ethambutol resistance in Mycobacterium tuberculosis. BMC Infect Dis. 2014;14:380. doi: 10.1186/1471-2334-14-380 PMID: 25011623; PubMed Central PMCID: PMCPMC4227065.
57. Huang Z, Qin C, Du J, Luo Q, Wang Y, Zhang W, et al. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study. J Antimicrob Chemother. 2014. doi: 10.1093/jac/dku384 PMID: 25266071.
58. Michael JS, Daley P, Kalaiselvan S, Latha A, Vijayakumar J, Mathai D, et al. Diagnostic accuracy of the microscopic observation drug susceptibility assay: a pilot study from India. Int J Tuberc Lung Dis. 2010;14(4):482-8. PMID: 20202307; PubMed Central PMCID: PMCPMC2951990.
59. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, et al. Microscopic-observation drugsusceptibility assay for the diagnosis of TB. N Engl J Med. 2006;355(15):1539-50. doi: 10.1056/NEJMoa055524 PMID: 17035648; PubMed Central PMCID: PMCPMC1780278.
60. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2007;45(4):1093-7. doi: 10.1128/JCM.01949-06 PMID: 17251409; PubMed Central PMCID: PMCPMC1865834.
61. Choi J, Jung YG, Kim J, Kim S, Jung Y, Na H, et al. Rapid antibiotic susceptibility testing by tracking single cell growth in a microfluidic agarose channel system. Lab Chip. 2013;13(2):280-7. doi: 10.1039/c2lc41055a PMID: 23172338.
62. Price CS, Kon SE, Metzger S. Rapid antibiotic susceptibility phenotypic characterization of Staphylococcus aureus using automated microscopy of small numbers of cells. J Microbiol Methods. 2014;98:50-8. doi: 10.1016/j.mimet.2013.12.021 PMID: 24393790.
63. Metzger S, Frobel RA, Dunne WM. Rapid simultaneous identification and quantitation of Staphylococcus aureus and Pseudomonas aeruginosa directly from bronchoalveolar lavage specimens using automated microscopy. Diagn Microbiol Infect Dis. 2014;79(2):160-5. doi: 10.1016/j.diagmicrobio.2013.11. 029 PMID: 24698367.
64. Douglas IS, Price CS, Overdier KH, Wolken RF, Metzger SW, Hance KR, et al. Rapid automated microscopy for microbiological surveillance of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2015;191(5):566-73. doi: 10.1164/rccm.201408-1468OC PMID: 25585163; PubMed Central PMCID: PMCPMC4384769.
65. Angeletti S, Dicuonzo G, Avola A, Crea F, Dedej E, Vailati F, et al. Viridans Group Streptococci clinical isolates: MALDI-TOF mass spectrometry versus gene sequence-based identification. PLoS One. 2015;10(3):e0120502. doi: 10.1371/journal.pone.0120502 PMID: 25781023; PubMed Central PMCID: PMCPMC4362942.
66. Calderaro A, Martinelli M, Motta F, Larini S, Arcangeletti MC, Medici MC, et al. Comparison of peptide nucleic acid fluorescence in situ hybridization assays with culture-based matrix-assisted laser desorption/ionization-time of flight mass spectrometry for the identification of bacteria and yeasts from blood cultures and cerebrospinal fluid cultures. Clin Microbiol Infect. 2014;20(8):O468-75. doi: 10.1111/1469-0691.12490 PMID: 24304149.
67. Makristathis A, Riss S, Hirschl AM. A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures. Clin Microbiol Infect. 2014;20(10):O760-3. doi: 10.1111/1469-0691.12561 PMID: 24450815.
68. Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, et al. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. Clin Infect Dis. 2015. doi: 10.1093/cid/civ447 PMID: 26197846.